Indications and Usage Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic (semaglutide) tablets 4 mg or 9 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes Ozempic injection is indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes and established CV disease to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Ozempic tablets are indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events References: Ozempic tablets
Ceramides in metabolism: key lipotoxic players
Typically, Ozempic is considered for weight loss in patients with a BMI of 27 or higher, particularly if they have additional weight-related health conditions, or a BMI of 30 or higher regardless of other health issues
To sustain this workload, heart tissue contains the highest concentration of mitochondria (cellular energy factories) of any muscle
Never reuse needles between sessions
Give the final dose 4-6 hours before hard work